OxStem Company

OxStem plans to develop small molecule drugs that can activate repair mechanisms that already exist within the body.
Building on decades of experience in medicinal chemistry, OxStem will design drugs that can programme resident stem and stem-like cells in situ to treat currently untreatable age-related conditions.
Technology: Cell Therapies
Industry: Regenerative Medicine
Headquarters: Oxford, Oxfordshire, United Kingdom
Founded Date: 2013
Employees Number: 1-10
Funding Status: N/A

Visit Website
Register and Claim Ownership